Correction to: Neutralizing Antibody Sample Testing and Report Harmonization

Darshana Jani¹, Michele Gunsior², Robin Marsden³, Kyra J Cowan⁴, Susan C Irvin⁵, Laura Schild Hay⁶, Bethany Ward⁶, Luke Armstrong⁷, Mitra Azadeh⁸, Liching Cao⁹, Rebecca Carmean⁶, Jason DelCarpini¹⁰, Sanjay L Dholakiya¹¹, Amanda Hays¹², Sarah Hosback¹³, Zheng Hu¹⁴, Nadia Kulagina¹⁵, Seema Kumar¹⁶, Ching Ha Lai⁵, Marit Lichtfuss¹³, Hsing-Yin Liu¹⁷, Susana Liu¹⁸, Reza Mozaffari¹⁹, Luying Pan²⁰, Jason Pennucci¹⁰, Marie-Eve Poupart²¹, Gurleen Saini²², Veerle Snoeck²³, Kristine Storey²⁴, Amy Turner¹⁵, Inna Vainshtein²⁵, Daniela Verthelyi²⁶, Iwona Wala²⁷, Lili Yang²⁸, Lin Yang²⁹

Affiliations

¹ Bioanalytical and Molecular Assays, Moderna, 325 Binney Street, Cambridge, Massachusetts, USA. darshana.jani@modernatx.com.
² Translational Sciences, Astria Therapeutics, Boston, Massachusetts, USA.
³ Revelation Biosciences, San Diego, California, USA.
⁴ Drug Metabolism & Pharmacokinetics, New Biological Entities, Merck KGaA, Darmstadt, Germany.
⁵ Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA.
⁶ Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA.
⁷ Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA.
⁸ Bioanalytical and Biomarker Development, Ultragenyx Pharmaceutical, Inc, Novato, California, USA.
⁹ Biomarker and BioAnalytical Sciences, Sangamo Therapeutics, Brisbane, California, USA.
¹⁰ Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA.
¹¹ Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA.
¹² Scientific Office, BioAgilytix Labs, Durham, North Carolina, USA.
¹³ Research and Clinical Bioanalytics, CSL, Melbourne, Australia.
¹⁴ Translational Safety & Bioanalytical Science, Amgen Inc, Thousand Oaks, California, USA.
¹⁵ Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA.
¹⁶ DMPK and Bioanalysis, Pioneering Medicines at Flagship Pioneering, Cambridge, Massachusetts, USA.
¹⁷ Janssen Research & Development LLC, Spring House, Montgomery County, Pennsylvania, USA.
¹⁸ Clinical Pharmacology, Biologics & Immunogenicity Clinical Assay Group, Pfizer Inc, Kirkland, Quebec, Canada.
¹⁹ Bioanalysis, Immunogenicity & Biomarkers (BIB), IVIVT, Research, GSK, Collegeville, Pennsylvania, USA.
²⁰ Takeda Development Center Americas Inc, Cambridge, Massachusetts, USA.
²¹ Charles River Laboratories, Senneville, Quebec, Canada.
²² Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
²³ Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, 1420, Braine-L'Alleud, Belgium.
²⁴ Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc, Rahway, New Jersey, USA.
²⁵ Discovery and Translational Research, Exelixis, Alameda, California, USA.
²⁶ Office of Pharmaceutical Quality Research, Division IV, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
²⁷ Translational Safety and Bioanalytical Sciences, Amgen, Thousand Oaks, California, USA.
²⁸ Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.
²⁹ Integrated Bioanalysis, AstraZeneca, Gaithersburg, MD, USA.

PMID: 39231893
DOI: 10.1208/s12248-024-00965-z

Published Erratum

Correction to: Neutralizing Antibody Sample Testing and Report Harmonization

Darshana Jani et al. AAPS J. 2024.

. 2024 Sep 4;26(5):98.

doi: 10.1208/s12248-024-00965-z.

Authors

Affiliations

¹ Bioanalytical and Molecular Assays, Moderna, 325 Binney Street, Cambridge, Massachusetts, USA. darshana.jani@modernatx.com.
² Translational Sciences, Astria Therapeutics, Boston, Massachusetts, USA.
³ Revelation Biosciences, San Diego, California, USA.
⁴ Drug Metabolism & Pharmacokinetics, New Biological Entities, Merck KGaA, Darmstadt, Germany.
⁵ Bioanalytical Sciences, Regeneron Pharmaceuticals, Tarrytown, New York, USA.
⁶ Bioanalytical Lab, PPD Clinical Research Business, Thermo Fisher Scientific, Richmond, Virginia, USA.
⁷ Bioanalytical Operations, BioAgilytix Labs, Durham, North Carolina, USA.
⁸ Bioanalytical and Biomarker Development, Ultragenyx Pharmaceutical, Inc, Novato, California, USA.
⁹ Biomarker and BioAnalytical Sciences, Sangamo Therapeutics, Brisbane, California, USA.
¹⁰ Bioanalytical Sciences, Moderna, Cambridge, Massachusetts, USA.
¹¹ Non-Clinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA.
¹² Scientific Office, BioAgilytix Labs, Durham, North Carolina, USA.
¹³ Research and Clinical Bioanalytics, CSL, Melbourne, Australia.
¹⁴ Translational Safety & Bioanalytical Science, Amgen Inc, Thousand Oaks, California, USA.
¹⁵ Pharmaceutical Development Services, Smithers, Gaithersburg, Maryland, USA.
¹⁶ DMPK and Bioanalysis, Pioneering Medicines at Flagship Pioneering, Cambridge, Massachusetts, USA.
¹⁷ Janssen Research & Development LLC, Spring House, Montgomery County, Pennsylvania, USA.
¹⁸ Clinical Pharmacology, Biologics & Immunogenicity Clinical Assay Group, Pfizer Inc, Kirkland, Quebec, Canada.
¹⁹ Bioanalysis, Immunogenicity & Biomarkers (BIB), IVIVT, Research, GSK, Collegeville, Pennsylvania, USA.
²⁰ Takeda Development Center Americas Inc, Cambridge, Massachusetts, USA.
²¹ Charles River Laboratories, Senneville, Quebec, Canada.
²² Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
²³ Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, 1420, Braine-L'Alleud, Belgium.
²⁴ Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc, Rahway, New Jersey, USA.
²⁵ Discovery and Translational Research, Exelixis, Alameda, California, USA.
²⁶ Office of Pharmaceutical Quality Research, Division IV, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
²⁷ Translational Safety and Bioanalytical Sciences, Amgen, Thousand Oaks, California, USA.
²⁸ Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.
²⁹ Integrated Bioanalysis, AstraZeneca, Gaithersburg, MD, USA.

PMID: 39231893
DOI: 10.1208/s12248-024-00965-z

No abstract available

PubMed Disclaimer

Erratum for

Neutralizing Antibody Sample Testing and Report Harmonization.
Jani D, Gunsior M, Marsden R, Cowan KJ, Irvin SC, Hay LS, Ward B, Armstrong L, Azadeh M, Cao L, Carmean R, DelCarpini J, Dholakiya SL, Hays A, Hosback S, Hu Z, Kulagina N, Kumar S, Lai CH, Lichtfuss M, Liu HY, Liu S, Mozaffari R, Pan L, Pennucci J, Poupart ME, Saini G, Snoeck V, Storey K, Turner A, Vainshtein I, Verthelyi D, Wala I, Yang L, Yang L. Jani D, et al. AAPS J. 2024 Jul 12;26(4):80. doi: 10.1208/s12248-024-00955-1. AAPS J. 2024. PMID: 38992280

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Neutralizing Antibody Sample Testing and Report Harmonization

Affiliations

Correction to: Neutralizing Antibody Sample Testing and Report Harmonization

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources